Chitosan formulations for steroid delivery: Effect of formulation variables on in vitro characteristics

Drug Development and Industrial Pharmacy

Volumn 33, Issue 3, 2007, Pages 265-271

  Eroǧlu, Hakan ^a   Sargon, Mustafa F ^a   Öner, Levent ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chitosan; Crosslinking; Film; In vitro release; Molecular weight

Indexed keywords

CHITOSAN; DEXAMETHASONE SODIUM PHOSPHATE; SOLVENT;

ARTICLE; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; EVAPORATION; FILM; IN VITRO STUDY; MAXILLOFACIAL SURGERY; MOLECULAR WEIGHT; POSTOPERATIVE PERIOD; STEROID THERAPY; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; THICKNESS; TIMED DRUG RELEASE;

BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; STEROIDS;

EID: 34247470239     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600713134     Document Type: Article

References (18)

1. Arica, B., Calis, S., Kas, H. S., Hincal, A. A. (2002). Chitosan microspheres of ibuprofen: evaluation and in vitro characterization. In Chitosan in Pharmacy and Chemistry; Muzzarelli, R. A. A. & Muzzarelli, C., Eds.; Atec: Italy; 71-76.
2. Bodmeier, R., Oh, K. H., & Pramar, Y. (1989). Preparation and evaluation of drug containing chitosan beads. Drug Dev. Ind. Pharm., 15, 1475-1494.
3. Brown, C. D., Kreilgaard, L., Nakakura, M., Caram-Lelham, N., Pettit, D. K., Gombotz, W. R., & Hoffman, A. S. (2001). Release of PEGylated granulocyte-macrophage colony stimulating factor from chitosan/glycerol films. J. Cont. Rel., 72, 35-46.
4. Chandy, T., & Sharma, C. P. (1991). Biodegradable chitosan matrix for the controlled release of steroids. Biomat. Artif. Cells Immobil. Biotechnol., 19, 745-760.
5. Denkbaş, E. B., & Odabaşi, M. (2000). Chitosan microspheres and sponges: Preparation and characterization. J. Appl. Polym. Sci., 76, 1637-1643.
6. Dureja, H., Tiwary, A. K., & Gupta, S. (2001). Simulation of skin permeability in chitosan membranes. Int. J. Pharm., 213, 193-198.
7. Entwistle, C. A., & Rowe, R. C. (1979). Plasticization of cellulose ethers used in film coating of tablets. J. Pharm. Pharmacol., 31, 269-272.
8. Fan, L. T., & Singh, S. K. (1989). Diffusion-controlled release. In Controlled Release-A Quantitative Treatment; Fan, L. T. & Singh, S. K., Eds.; Springer-Verlag: Berlin; 61-79.
9. Freitas, S., Merkle, H. P., & Gander, B. (2005). Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology. J. Control. Rel., 102, 313-332.
10. Griffies, W. S., Kennedy, K., Gasser, C., Fankhauser, C., & Taylor, R. (1989). Steroids in rhinoplasty. Laryngoscope, 99, 1161-1164.
11. Hirano, S., Tsuchida, H., & Nagao, N. (1989). N-Acetylation in chitosan and the rate of its enzyme hydrolysis. Biomaterials, 10, 574-576.
12. Lim, L. Y., Lucy, S. C. W., & Thai, P. Y. (1997). Chitosan microspheres prepared by emulsification and ionotropic gelation. Drug. Dev. Ind. Pharm., 23, 981-985.
13. Martins, A. O., Silva, E. L., Carasek, E., Laranjeira, M. C. M., & Favere, V. T. (2004). Sulphoxide immobilized onto chitosan microspheres by spray drying: application for metal ions preconcentration by flow injection analysis. Talanta, 63, 397-403.
14. Pangburn, S. H., Trescony, P. V., & Heller, J. (1982). Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials, 3, 105-108.
15. Sawayanagi, Y., Nambu, N., & Nagai, T. (1982). Permeation of drugs through chitosan membranes. Chem. Pharm. Bull., 30, 3297-3301.
16. Şenel, S., İkinci, G., Kaş, S., Yousefi-Rad, A., Sargon, M. F., & Hincal, A. A. (2000). Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int. J. Pharm., 193, 197-203.
17. Shu, X. Z., & Zhu, K. J. (2000). A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm., 201, 51-58.
18. Siepmann, J., Lecomte, F., & Bodmeier, R. (1999). Diffusion controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J. Conrol. Rel., 60, 379-389.